Search research articles
Contact Us
Filters
Showing results (121-130 of 125) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 125 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
Lancet (London, England)
|
March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
, R Arriagada, A Auperin, et al.
The Pharmacogenomics Journal
|
April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
M M Dias, J-P Pignon, C S Karapetis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial
B Besse, J Mazières, L Ribassin-Majed, et al.
Pediatric Blood & Cancer
|
January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)
Brice Fresneau, A Hackshaw, D S Hawkins, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 125) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 125 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
Lancet (London, England)
|
March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
, R Arriagada, A Auperin, et al.
The Pharmacogenomics Journal
|
April 9, 2014
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
M M Dias, J-P Pignon, C S Karapetis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial
B Besse, J Mazières, L Ribassin-Majed, et al.
Pediatric Blood & Cancer
|
January 24, 2017
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)
Brice Fresneau, A Hackshaw, D S Hawkins, et al.
Page
of 13